Regarding the gene expression of Bcl-2, which plays an important role in regulating the survival of the cell and acts as an anti-apoptotic agent, our study estimated its level in all study subjects and the work revealed an increase in the serum level of Bcl-2 in thyroid cancer patients in both stages I and II. This evidence concerns the gene BCL2 and thyroid cancer.